Pharmaceutical Companies
GlycoMimetics, Inc.
๐บ๐ธUnited States
Jaguar Health
๐บ๐ธUnited States
AGILE THERAPEUTICS INC
๐บ๐ธUnited States
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $10.4M
- Website
- -
Eterna Therapeutics
๐บ๐ธUnited States
- Ownership
- -
- Established
- -
- Employees
- 8
- Market Cap
- $9.6M
- Website
- -
Eterna Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The compa...
Redhill Biopharma
๐ฎ๐ฑIsrael
RedHill Biopharma Ltd. develops medicines for gastrointestinal and infectious diseases. It operates through Commercial Operations, and the Research and Development segments. The Commercial Operations segment covers all areas relating to the...
Organovo, Inc.
๐บ๐ธUnited States
- Ownership
- Public, Subsidiary
- Established
- 2007-01-01
- Employees
- 51
- Market Cap
- $9.4M
- Website
- http://www.organovo.com
Bionomics, Inc.
๐บ๐ธUnited States
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $9.1M
- Website
- -
Vaccinex
๐บ๐ธUnited States
- Ownership
- Public, Subsidiary
- Established
- 1997-01-01
- Employees
- 40
- Market Cap
- $9M
- Website
- http://www.vaccinex.com
Vaccinex, Inc. operates as a clinical-stage biotechnology company. It engages in the development of targeted bio therapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, a...
Soligenix
๐บ๐ธUnited States
Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. It operates through the Specialized BioTherapeutics and Public Health Solutions segments. ...
Viracta Therapeutics
๐บ๐ธUnited States
Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therap...
